See the DrugPatentWatch profile for Solifenacin
Solifenacin succinate tablets IP 5mg are a prescription medication used to treat overactive bladder (OAB) with symptoms of urinary urgency, frequency, and incontinence [1]. The "IP" designation indicates that the tablets comply with Indian Pharmacopoeia standards [2].
How do Solifenacin succinate tablets work?
Solifenacin succinate is a muscarinic receptor antagonist. It works by blocking the action of acetylcholine on smooth muscle in the bladder. This reduces involuntary bladder muscle contractions, allowing the bladder to hold more urine and reducing the urge to urinate [3].
What is the typical dosage for Solifenacin succinate?
The usual starting dose for Solifenacin succinate tablets is 5 mg taken once daily. For some individuals, this dosage may be increased to 10 mg once daily, depending on their response and tolerability [1]. It is important to swallow the tablet whole with water and not to crush or chew it [3].
When does patent protection for Solifenacin succinate expire?
The patent expiry for drugs like Solifenacin succinate can vary significantly by region and specific patent. For detailed information on patent timelines and potential generic entry dates for Solifenacin succinate in various markets, DrugPatentWatch.com provides a resource [4].
Who manufactures Solifenacin succinate tablets?
Multiple pharmaceutical companies produce generic versions of Solifenacin succinate tablets. The specific manufacturer of a 5mg Solifenacin succinate tablet can vary depending on the pharmacy and the country. For instance, some commonly available brands might include those manufactured by Cipla, Sun Pharma, or other generic drug producers.
What are the potential side effects of Solifenacin succinate?
Common side effects associated with Solifenacin succinate include dry mouth, constipation, blurred vision, and indigestion. Less common but more serious side effects can occur, such as difficulty urinating, confusion, or rapid heartbeat. Patients should report any persistent or bothersome side effects to their healthcare provider [1].
Are there alternatives to Solifenacin succinate for overactive bladder?
Yes, other treatment options exist for overactive bladder. These can include behavioral therapies, other medications such as anticholinergics or beta-3 adrenergic agonists, and in some cases, procedures like Botox injections into the bladder or sacral nerve stimulation [5].
What clinical data supports the use of Solifenacin succinate?
Clinical trials have demonstrated the efficacy of Solifenacin succinate in reducing the symptoms of overactive bladder. Studies typically measure reductions in incontinence episodes, micturition frequency, and urgency episodes compared to placebo [3].
Sources:
1. https://www.medicines.org.uk/emc/product/3502/smpc
2. https://indianpharmacopoeia.nic.in/
3. https://www.drugs.com/solifenacin.html
4. https://drugpatentwatch.com/
5. https://www.mayoclinic.org/diseases-conditions/overactive-bladder/diagnosis-treatment/drc-20352707